Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey S Chamberlain

Showing results (31-40 of 166) with videos related to

Pageof 17
Sort By:
Muscle & Nerve|June 15, 2010
Sequencing protocols to genotype mdx, mdx(4cv), and mdx(5cv) miceGlen B Banks, Ariana C Combs, Jeffrey S Chamberlain
Methods in Molecular Biology (Clifton, N.J.)|October 26, 2017
AAV6 Vector Production and Purification for Muscle Gene TherapyChristine L Halbert, James M Allen, Jeffrey S Chamberlain
Plos Genetics|November 11, 2020
Microutrophin expression in dystrophic mice displays myofiber type differences in therapeutic effectsGlen B Banks, Jeffrey S Chamberlain, Guy L Odom
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|January 9, 2025
Correction: Dystrophin- and Utrophin-Based Therapeutic Approaches for Treatment of Duchenne Muscular Dystrophy: A Comparative ReviewSylwia Szwec, Zuzanna Kapłucha, Jeffrey S Chamberlain, et al.
Current Pediatrics Reports|June 3, 2014
Therapy of Genetic Disorders-Novel Therapies for Duchenne Muscular DystrophyJane T Seto, Niclas E Bengtsson, Jeffrey S Chamberlain
Molecular and Cellular Neurosciences|January 28, 2009
Truncated dystrophins can influence neuromuscular synapse structureGlen B Banks, Jeffrey S Chamberlain, Stanley C Froehner
Stem Cells and Development|August 10, 2016
Prosurvival Factors Improve Functional Engraftment of Myogenically Converted Dermal Cells into Dystrophic Skeletal MuscleLindsey A Muir, Charles E Murry, Jeffrey S Chamberlain
Human Molecular Genetics|August 1, 2025
Bidirectional role of Costameres in the pathophysiology of mdx skeletal musclesGlen B Banks, Darren R Bisset, Jeffrey S Chamberlain
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 2, 2023
Dystrophin- and Utrophin-Based Therapeutic Approaches for Treatment of Duchenne Muscular Dystrophy: A Comparative ReviewSylwia Szwec, Zuzanna Kapłucha, Jeffrey S Chamberlain, et al.
Current Opinion in Genetics & Development|May 5, 2009
Therapy for neuromuscular disordersAndrea L H Arnett, Joel R Chamberlain, Jeffrey S Chamberlain
Pageof 17

Showing results (31-40 of 166) with videos related to

Sort By:
Pageof 17
Muscle & Nerve|June 15, 2010
Sequencing protocols to genotype mdx, mdx(4cv), and mdx(5cv) miceGlen B Banks, Ariana C Combs, Jeffrey S Chamberlain
Methods in Molecular Biology (Clifton, N.J.)|October 26, 2017
AAV6 Vector Production and Purification for Muscle Gene TherapyChristine L Halbert, James M Allen, Jeffrey S Chamberlain
Plos Genetics|November 11, 2020
Microutrophin expression in dystrophic mice displays myofiber type differences in therapeutic effectsGlen B Banks, Jeffrey S Chamberlain, Guy L Odom
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|January 9, 2025
Correction: Dystrophin- and Utrophin-Based Therapeutic Approaches for Treatment of Duchenne Muscular Dystrophy: A Comparative ReviewSylwia Szwec, Zuzanna Kapłucha, Jeffrey S Chamberlain, et al.
Current Pediatrics Reports|June 3, 2014
Therapy of Genetic Disorders-Novel Therapies for Duchenne Muscular DystrophyJane T Seto, Niclas E Bengtsson, Jeffrey S Chamberlain
Molecular and Cellular Neurosciences|January 28, 2009
Truncated dystrophins can influence neuromuscular synapse structureGlen B Banks, Jeffrey S Chamberlain, Stanley C Froehner
Stem Cells and Development|August 10, 2016
Prosurvival Factors Improve Functional Engraftment of Myogenically Converted Dermal Cells into Dystrophic Skeletal MuscleLindsey A Muir, Charles E Murry, Jeffrey S Chamberlain
Human Molecular Genetics|August 1, 2025
Bidirectional role of Costameres in the pathophysiology of mdx skeletal musclesGlen B Banks, Darren R Bisset, Jeffrey S Chamberlain
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 2, 2023
Dystrophin- and Utrophin-Based Therapeutic Approaches for Treatment of Duchenne Muscular Dystrophy: A Comparative ReviewSylwia Szwec, Zuzanna Kapłucha, Jeffrey S Chamberlain, et al.
Current Opinion in Genetics & Development|May 5, 2009
Therapy for neuromuscular disordersAndrea L H Arnett, Joel R Chamberlain, Jeffrey S Chamberlain
Pageof 17